CIK 0001937993 · <br>Emerging growth company
Cadrenal Therapeutics, Inc.
Sign in to watch- Ticker
- CVKD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880860746
- Phone
- 904-300-0701
- Business address
- 822 A1A NORTH, SUITE 306, PONTE VEDRA, FL, 32082
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Shareholder vote results
- 4 Open-market buy Director bought 20,000 shares at an average $0.70 ($13,973)
- 8-K Event Delisting notice
- 4 Open-market buy CEO and Chairman bought 40,000 shares at an average $0.90 ($36,188)
- 4 Open-market buy CEO and Chairman bought 70,000 shares at an average $0.91 ($63,945)
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 8-K Event Regulation FD disclosure
- 8-K Event Director nominations · Other events
- 424B3 Offering Prospectus
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
Page 11 of 14 · 277 filings